Brief: Coherus Announces U.S. Launch Of UDENYCA ONBODY
21/02/2024 14:41
Feb 21 (Reuters) - Coherus BioSciences Inc CHRS.O :
* COHERUS ANNOUNCES U.S. LAUNCH OF UDENYCA ONBODY™ A NOVEL
AND
PROPRIETARY STATE-OF-THE-ART DELIVERY SYSTEM FOR
PEGFILGRASTIM-CBQV
Source text for Eikon: ID:nGNXNrSyB
Further company coverage: CHRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Coherus Oncology
See all newsBrief: Coherus Oncology Initiates Process To Sell Legacy Biosim Assets
Brief: Coherus Oncology Announces Special Dividend Of Biosimilar Contingent Value Rights
Coherus Oncology Inc reports results for the quarter ended June 30 - Earnings Summary
Coherus Oncology Q2 revenue rises 40% on higher LOQTORZI volume, but slightly falls below estimates
Brief: Coherus Oncology Q2 Net Income USD -20.631 Million